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KapLan-Meier analysis of time to death from any 
cause showed significant survival benefit in favor 
of POS (P = 0.035). 
Deaths among patients with probable or proven breakthrough 
IFI during prophylaxis 
Patients with IFI POS (n=7) FLU/ITZ (n =25) 
Total deaths, n (%) 1 (14) 11 (44) 
Cause of death, n (%) 
Progression of IFI 0 8 (32) 
AML/MDS 0 2 (8) 
Intercurrent illness 1 (14) 1 (4) 
Conclusions: In this study, among 32 AML/MDS pa- 
tients with IFIs, mortality rates were high (44% in 
the standard azoLe group and 14% in the POS 
group). An early intervention strategy such as 
POS prophylaxis, which significantly decreases the 
incidence of IFI, may be more effective than wait- 
ing to treat established IFI. 
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Background: The most common disease associa- 
tion of the mould Scopulariopsis is onychomycosis. 
However, in addition, there now exists a smaLL but 
increasing number of reports of invasive infections, 
with high associated mortality, in immunocompro- 
mised patients receiving therapy for malignancies 
or in receipt of bone marrow or solid organ trans- 
plants. 
Objectives: To describe an unusual case of infec- 
tion by Scopulariopsis brevicaulis in a paediatric 
patient with acute [ymphobLastic [eukaemia (ALL) 
and review the Literature on invasive infection 
by Scopulariopsis spp. in immunocompromised pa- 
tients. 
Methods: Case report and Literature review. An- 
tifunga[ MICs were determined at the HPA My- 
cology Reference Laboratory, BristoL, UK. Case: A 
10-year-oLd girl receiving maintenance chemother- 
apy after relapse of ALL foLLowing bone marrow 
transplantation was admitted with fever and a 
dry cough. Her CRP Level was 141 mg/L and her 
absolute neutrophi[ count was 2.1×109/L. BLood 
cultures at this time were negative. ACT  scan 
revealed muLtipLe pulmonary Lesions suggestive of 
funga[ pneumonia. AmBisome was added to em- 
pirical antibiotic therapy. Bronchial [avage was 
not performed. BLood cultures taken 10 days Later 
yielded S. brevicaulis. VoriconazoLe was added 
but blood cultures remained intermittently pos- 
itive. Antifunga[ susceptibility results were then 
received (amphotericin B MIC: 1 mg/L, voricona- 
zoLe: 8 mg/L, itraconazoLe: 16 mg/L, caspofungin: 
4mg/L and terbinafine: 0.5mg/L). The addition 
of oral terbinafine was associated with microbio- 
Logical response and complete resolution of fever. 
AmBisome was Later discontinued and the patient 
discharged. To date, she remains asymptomatic 
and apyrexia[ on oral voriconazoLe and terbinafine. 
However, some pulmonary Lesions remain. 
Results/Conclusions: Review of the Literature in- 
dicates that isolation of Scopulariopsis spp. from 
blood cultures is rare and resistance or reduced 
susceptibility to antifunga[ agents compromises 
therapy of infection. However, in the case pre- 
sented here, blood cultures were positive on 5 oc- 
casions, aLLowing definitive identification and an- 
tifunga[ susceptibility testing, which guided sub- 
sequent therapy. In addition, neutrophi[ counts of 
>1.0×109/L throughout the period of fungaemia 
probably influenced the cLinicaL outcome, which 
was superior to that of the majority of reported 
cases of Scopulariopsis spp. invasive infection in 
immunocompromised patients. 
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Background: Antibiotic-Locks have been shown to 
prevent CVC-reLated bloodstream infection in pts 
with tunneled CVC. An ethanoL-Lock might be a 
good alternative because it has a broad antimi- 
crobia[ spectrum and does not carry the risk of 
selection of antibiotic-resistant microorganisms. 
ObJectives: To evaluate safety and toLerabiLity of 
70% ethanol CVC-Lock. 
Materials & Methods: HematoLogy pts who had 
tunneLLed polyurethane CVC inserted during hos- 
pital stay for chemotherapy were randomized to 
70% ethanol Lock or placebo (NaC[ 0.9%). Lumina 
were Locked for 15rain/day during hospitaLiza- 
tion and 1 ×/week otherwise. EthanoL/pLacebo was 
flushed sLowLy through the CVC afterwards. Liver 
enzymes (g-GT, ASAT) and MCV on cl0 and d14 
were measured and pts were asked to fiLL out a 
questionary on side effects. Recruitment of 440 pts 
is ongoing. This abstract reports on a planned 
